Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1996-1-4
pubmed:abstractText
To investigate the relationship between metabolic and vascular factors, especially polyol pathway and platelet aggregation, in the pathogenesis of diabetic neuropathy, the effects of a novel potent aldose reductase inhibitor, TAT ((5-(3-thienyl) tetrazol-1-yl) acetic acid monohydrate) on adenosine diphosphate-induced platelet aggregation, polyol contents in platelets, motor nerve conduction velocity (MNCV), and sciatic nerve blood flow (SNBF) were examined in streptozotocin-induced diabetic rats. Diabetic rats demonstrated hyperaggregation in response to adenosine diphosphate, accompanied by sorbitol and fructose accumulation and myoinositol depletion in platelets. Treatment with TAT improved these abnormalities in diabetic rats. A delayed MNCV and a reduced SNBF in diabetic rats were normalized by the administration of TAT. These observations suggest that increased polyol pathway activity plays an important role in platelet aggregation in the development of diabetic neuropathy and that aldose reductase inhibitor is useful for the treatment of diabetic neuropathy from the viewpoint not only of metabolic factors but also of vascular factors.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0022-2143
pubmed:author
pubmed:issnType
Print
pubmed:volume
126
pubmed:owner
NLM
pubmed:authorsComplete
N
pubmed:pagination
541-7
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:7490513-Adenosine Diphosphate, pubmed-meshheading:7490513-Aldehyde Reductase, pubmed-meshheading:7490513-Ampholyte Mixtures, pubmed-meshheading:7490513-Animals, pubmed-meshheading:7490513-Blood Glucose, pubmed-meshheading:7490513-Blood Platelets, pubmed-meshheading:7490513-Diabetes Mellitus, Experimental, pubmed-meshheading:7490513-Diabetic Neuropathies, pubmed-meshheading:7490513-Enzyme Inhibitors, pubmed-meshheading:7490513-Male, pubmed-meshheading:7490513-Neural Conduction, pubmed-meshheading:7490513-Platelet Aggregation, pubmed-meshheading:7490513-Polymers, pubmed-meshheading:7490513-Rats, pubmed-meshheading:7490513-Rats, Wistar, pubmed-meshheading:7490513-Sciatic Nerve, pubmed-meshheading:7490513-Streptozocin, pubmed-meshheading:7490513-Tetrazoles, pubmed-meshheading:7490513-Thiophenes
pubmed:year
1995
pubmed:articleTitle
An aldose reductase inhibitor, TAT, reduces ADP-induced platelet hyperaggregation in streptozotocin-induced diabetic rats with neuropathy.
pubmed:affiliation
Third Department of Internal Medicine, Nagoya University School of Medicine, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't